Atlas Trials

Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis

Clinical trial NCT03508570 · COMPLETED

Trial details

NCT number
NCT03508570
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Peritoneal NeoplasmMalignant Retroperitoneal NeoplasmMetastatic Cervical CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube CarcinomaMetastatic Malignant Female Reproductive System NeoplasmMetastatic Ovarian CarcinomaMetastatic Primary Peritoneal CarcinomaPeritoneal CarcinomatosisPlatinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Malignant Female Reproductive System NeoplasmPlatinum-Refractory Ovarian Carcinoma
Start date
2018-09-21
Primary completion
2024-11-11
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.